Takaki Yoshikawa
About
Takaki Yoshikawa is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology.
According to data from OpenAlex, Takaki Yoshikawa has authored 502 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 385 papers in Pulmonary and Respiratory Medicine, 212 papers in Surgery and 176 papers in Gastroenterology. Recurrent topics in Takaki Yoshikawa's work include Gastric Cancer Management and Outcomes (356 papers), Metastasis and carcinoma case studies (184 papers) and Gastrointestinal Tumor Research and Treatment (176 papers). Takaki Yoshikawa is often cited by papers focused on Gastric Cancer Management and Outcomes (356 papers), Metastasis and carcinoma case studies (184 papers) and Gastrointestinal Tumor Research and Treatment (176 papers). Takaki Yoshikawa collaborates with scholars based in Japan, United States and United Kingdom. Takaki Yoshikawa's co-authors include Akira Tsuburaya, Toru Aoyama, Haruhiko Cho, Mitsuru Sasako, Masanori Terashima, Hitoshi Katai, Tsutomu Hayashi, Yasushi Rino, Junki Mizusawa and Takanobu Yamada and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Takaki Yoshikawa
466 papers receiving 10.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Takaki Yoshikawa Japan | 51 | 7.3k | 4.5k | 3.2k | 2.9k | 1.0k | 502 | 10.8k | ||
| Takahisa Matsuda Japan | 62 | 8.0k 1.1× | 4.0k 0.9× | 3.0k 0.9× | 5.6k 2.0× | 1.0k 1.0× | 310 | 11.7k | ||
| Magnus Nilsson Sweden | 35 | 4.5k 0.6× | 4.9k 1.1× | 1.3k 0.4× | 1.9k 0.7× | 1.5k 1.5× | 170 | 8.3k | ||
| Yukinori Kurokawa Japan | 51 | 6.3k 0.9× | 5.2k 1.2× | 2.5k 0.8× | 2.6k 0.9× | 1.8k 1.7× | 486 | 10.8k | ||
| Hiroya Takeuchi Japan | 49 | 5.1k 0.7× | 5.1k 1.1× | 1.1k 0.3× | 2.8k 1.0× | 1.3k 1.3× | 402 | 9.6k | ||
| Giuseppe Aprile Italy | 38 | 5.0k 0.7× | 2.5k 0.6× | 1.3k 0.4× | 5.6k 2.0× | 2.0k 1.9× | 232 | 9.8k | ||
| Hitoshi Katai Japan | 59 | 9.0k 1.2× | 4.9k 1.1× | 4.5k 1.4× | 2.4k 0.8× | 1.5k 1.4× | 277 | 11.8k | ||
| Masayuki Kitano Japan | 49 | 3.3k 0.5× | 4.8k 1.1× | 518 0.2× | 4.6k 1.6× | 471 0.4× | 317 | 7.7k | ||
| Eiji Oki Japan | 53 | 3.5k 0.5× | 3.3k 0.7× | 658 0.2× | 4.5k 1.6× | 3.5k 3.4× | 617 | 10.9k | ||
| Byung‐Ho Nam South Korea | 47 | 2.9k 0.4× | 1.7k 0.4× | 970 0.3× | 1.5k 0.5× | 482 0.5× | 159 | 5.8k | ||
| Simon Law Hong Kong | 53 | 4.9k 0.7× | 6.1k 1.3× | 492 0.2× | 2.1k 0.7× | 3.0k 2.9× | 275 | 10.5k |
Countries citing papers authored by Takaki Yoshikawa
Since
Specialization
Citations
This map shows the geographic impact of Takaki Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takaki Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takaki Yoshikawa more than expected).
Fields of papers citing papers by Takaki Yoshikawa
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Takaki Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takaki Yoshikawa. The network helps show where Takaki Yoshikawa may publish in the future.
Co-authorship network of co-authors of Takaki Yoshikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Takaki Yoshikawa. A scholar is included among the top collaborators of Takaki Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takaki Yoshikawa. Takaki Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nishina, Tomohiro, Narikazu Boku, Yukinori Kurokawa, et al.. (2024). A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group. Japanese Journal of Clinical Oncology. 54(10). 1100–1106.
2.
Takeuchi, Chihiro, Satoshi Yamashita, Yuyu Liu, et al.. (2023). Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 73(2). 255–267.
3.
Yoshikawa, Takaki, Yasunori Nishida, Takanobu Yamada, et al.. (2023). Five-year follow-up results of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer: JCOG1104 (OPAS-1).. Journal of Clinical Oncology. 41(4_suppl). 381–381.
4.
Sato, Reo, Masanori Tokunaga, Junki Mizusawa, et al.. (2023). Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002. World Journal of Surgery. 48(1). 163–174.
5.
Terashima, Masanori, Kazumasa Fujitani, Han‐Kwang Yang, et al.. (2023). Role of reduction gastrectomy in patients with gastric cancer with a single non‐curable factor: Supplementary analysis of REGATTA trial. Annals of Gastroenterological Surgery. 7(5). 741–749.
6.
Akiyama, Yuji, Hitoshi Katai, Souya Nunobe, et al.. (2023). Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912). Journal of Gastroenterology. 58(6). 519–526.
7.
Hironaka, Shuichi, Ryo Sadachi, Nozomu Machida, et al.. (2021). Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013. Japanese Journal of Clinical Oncology. 52(1). 14–23.
8.
Sato, Yuya, Takanobu Yamada, Takaki Yoshikawa, et al.. (2020). Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC). Japanese Journal of Clinical Oncology. 50(11). 1321–1324.
9.
Sato, Yuya, Yukinori Kurokawa, Yuichiro� Doki, et al.. (2020). A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704). Future Oncology. 16(4). 31–38.
10.
Terashima, Masanori, Takaki Yoshikawa, Narikazu Boku, et al.. (2020). Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives. Japanese Journal of Clinical Oncology. 50(5). 528–534.
11.
Oba, Koji, Tsutomu Hayashi, Takanobu Yamada, et al.. (2020). Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer. World Journal of Surgery. 44(4). 1209–1215.
12.
Shitara, Kohei, Hiroki Hara, Takaki Yoshikawa, et al.. (2019). Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial. International Journal of Clinical Oncology. 25(2). 301–311.
13.
Terasawa, Teruhiko, Chisato Hamashima, Katsuaki Kato, et al.. (2019). Helicobacter pylorieradication treatment for gastric carcinoma prevention in asymptomatic or dyspeptic adults: systematic review and Bayesian meta-analysis of randomised controlled trials. BMJ Open. 9(9). e026002–e026002.
14.
Kano, Kazuki, Toru Aoyama, Yukio Maezawa, et al.. (2017). Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospective analysis. BMC Cancer. 17(1). 812–812.
15.
Yamada, Takanobu, Akira Tsuburaya, Tsutomu Hayashi, et al.. (2016). Usefulness of Surgical Apgar Score on Predicting Survival After Surgery for Gastric Cancer. Annals of Surgical Oncology. 23(S5). 757–763.
16.
Aoyama, Toru, Takaki Yoshikawa, Yohei Miyagi, et al.. (2013). Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomy. Surgery Today. 43(12). 1390–1397.
17.
Yoshikawa, Takaki, Akira Tsuburaya, Osamu Kobayashi, et al.. (2003). A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.. PubMed. 50(54). 2259–63.
18.
Yoshikawa, Takaki, et al.. (1999). Insulin resistance was connected with the alterations of substrate utilization in patients with cancer. Cancer Letters. 141(1-2). 93–98.
19.
Noguchi, Yoshikazu, Takaki Yoshikawa, Tatsuo Makino, et al.. (1993). Long-term total parenteral nutrition and osteoporosis: Report of a case. Surgery Today. 23(11). 1027–1031.
20.
Yoshikawa, Takaki, et al.. (1976). [Down's syndrome associated with acute leukemia].. PubMed. 34(6). 1292–300.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Takahisa Matsuda Breakdown of academic impact, for papers by Magnus Nilsson Breakdown of academic impact, for papers by Yukinori Kurokawa Breakdown of academic impact, for papers by Hiroya Takeuchi Breakdown of academic impact, for papers by Giuseppe Aprile Breakdown of academic impact, for papers by Hitoshi Katai Breakdown of academic impact, for papers by Masayuki Kitano Breakdown of academic impact, for papers by Eiji Oki Breakdown of academic impact, for papers by Byung‐Ho Nam Breakdown of academic impact, for papers by Simon Law